Analysis of Multiple HPV E6 PDZ Interactions Defines Type-Specific PDZ Fingerprints That Predict Oncogenic Potential

PLoS Pathogens

Volumn 12, Issue 8, 2016, Pages

  Thomas, Miranda ^a   Myers, Michael P ^a   Massimi, Paola ^a   Guarnaccia, Corrado ^a   Banks, Lawrence ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 SYNTROPHIN; PDZ DOMAIN PROTEIN; PROTEIN E6; PROTEIN ZO1; SMALL INTERFERING RNA; SYNTROPHIN; UNCLASSIFIED DRUG; ONCOPROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNA BINDING MOTIF; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; KERATINOCYTE; MASS SPECTROMETRY; NONHUMAN; PHYLOGENY; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN ISOLATION; PROTEIN PURIFICATION; PROTEOMICS; WART VIRUS; CELL LINE; METABOLISM; PAPILLOMAVIRIDAE; PDZ DOMAIN;

CARCINOGENESIS; CELL LINE; HUMANS; MASS SPECTROMETRY; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PDZ DOMAINS; PROTEOMICS;

EID: 84984830261     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005766     Document Type: Article

References (45)

1. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 100(B): Biological agents. 2012. WHO Press, ISBN13 9789283213192
2. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al; WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens–Part B: biological agents. Lancet Oncol. 2009; 10(4): 321–2. 19350698
3. Thomas M, Narayan N, Pim D, Tomaić V, Massimi P, Nagasaka K, et al. Human papillomaviruses, cervical cancer and cell polarity. Oncogene. 2008; 27(55): 7018–30doi: 10.1038/onc.2008.35119029942
4. Münger K, Werness BA, Dyson N, Phelps WC, Harlow E, Howley PM, Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J. 1989; 8(13): 4099–105. 2556261
5. Boyer SN, Wazer DE, Band V, E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res. 1996; 56(20): 4620–4. 8840974
6. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM, The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 1990; 63(6): 1129–36. 2175676
7. Thomas M, Banks L, Inhibition of Bak-induced apoptosis by HPV-18 E6. Oncogene. 1998; 17(23): 2943–54. 9881696
8. Thomas M, Banks L, Human papillomavirus (HPV) E6 interactions with Bak are conserved amongst E6 proteins from high and low risk HPV types. J Gen Virol. 1999; 80(6): 1513–1517
9. Nguyen ML, Nguyen MM, Lee D, Griep AE, Lambert PF, The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo. J Virol. 2003; 77(12): 6957–64. 12768014
10. Lee C, Laimins LA, Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31. J Virol. 2004; 78(22): 12366–77. 15507623
11. Nicolaides L, Davy C, Raj K, Kranjec C, Banks L, Doorbar J, Stabilization of HPV16 E6 protein by PDZ proteins, and potential implications for genome maintenance. Virology. 2011; 414(2): 137–45. doi: 10.1016/j.virol.2011.03.01721489588
12. Delury CP, Marsh EK, James CD, Boon SS, Banks L, Knight GL, Roberts S, The role of protein kinase A regulation of the E6 PDZ-binding domain during the differentiation-dependent life cycle of human papillomavirus type 18. J Virol. 2013; 87(17): 9463–72doi: 10.1128/JVI.01234-1323804647
13. Brimer N, Vande Pol SB, Papillomavirus E6 PDZ interactions can be replaced by repression of p53 to promote episomal human papillomavirus genome maintenance. J Virol. 2014; 88(5): 3027–30doi: 10.1128/JVI.02360-1324352452
14. Kiyono T, Hiraiwa A, Fujita M, Hayashi Y, Akiyama T, Ishibashi M, Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc Natl Acad Sci U S A. 1997; 94(21): 11612–69326658
15. Watson RA, Thomas M, Banks L, Roberts S, Activity of the human papillomavirus E6 PDZ-binding motif correlates with an enhanced morphological transformation of immortalized human keratinocytes. J Cell Sci, 2003; 116: 4925–493414625386
16. Shai A, Pitot HC Lambert PF, E6-associated protein is required for human papillomavirus type 16 E6 to cause cervical cancer in mice. Cancer Res. 2010; 70 (12): 5064–5073doi: 10.1158/0008-5472.CAN-09-330720530688
17. Subbaiah VK, Kranjec C, Thomas M, Banks L, PDZ domains: the building blocks regulating tumorigenesis. Biochem J. 2011; 439(2): 195–205doi: 10.1042/BJ2011090321954943
18. Javier R, Cell polarity proteins: common targets for tumorigenic human viruses. Oncogene. 2008; 27 (55): 7031–46. doi: 10.1038/onc.2008.35219029943
19. Pim D, Bergant M, Boon SS, Ganti K, Kranjec C, Massimi P, et al., Human papillomaviruses and the specificity of PDZ domain targeting. FEBS J. 2012; 279 (19): 3530–37. doi: 10.1111/j.1742-4658.2012.08709.x22805590
20. Zhang Y, Dasgupta J, Ma RZ, Banks L, Thomas M, Chen XS, Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein. J Virol. 2007; 81(7): 3618–26. 17267502
21. Belotti E, Polanowska J, Daulat AM, Audebert S, Thomé V, Lissitzky JC, et al. The human PDZome: a gateway to PSD95-Disc large-zonula occludens (PDZ)-mediated functions. Mol Cell Proteomics. 2013; 12(9): 2587–603doi: 10.1074/mcp.O112.02102223722234
22. Vincentelli R, Luck K, Poirson J, Polanowska J, Abdat J, Blémont M, et al., Quantifying domain-ligand affinities and specificities by high-throughput holdup assay. Nat Methods. 2015; 12(8): 787–93. doi: 10.1038/nmeth.343826053890
23. Thomas M, Dasgupta J, Zhang Y, Chen X, Banks L, Analysis of specificity determinants in the interactions of different HPV E6 proteins with their PDZ domain-containing substrates. Virology. 2008; 376(2): 371–8. doi: 10.1016/j.virol.2008.03.02118452965
24. Luck K, Charbonnier S, Travé G, The emerging contribution of sequence context to the specificity of protein interactions mediated by PDZ domains. FEBS Lett. 2012; 586(17): 2648–61doi: 10.1016/j.febslet.2012.03.05622709956
25. Van Doorslaer K, DeSalle R, Einstein MH, Burk RD, Degradation of human PDZ-proteins by human alphapapillomaviruses represents an evolutionary adaptation to a novel cellular niche. PLoS Pathog. 2015;11(6):e1004980doi: 10.1371/journal.ppat.100498026086730
26. Fournane S, Charbonnier S, Chapelle A, Kieffer B, Orfanoudakis G, Travé et al. Surface plasmon resonance analysis of the binding of high-risk mucosal HPV E6 oncoproteins to the PDZ1 domain of the tight junction protein MAGI-1. J Mol Recognit. 2011; 24(4): 511–23. doi: 10.1002/jmr.105620842623
27. Lee SS, Weiss RS, Javier RT, Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. Proc Natl Acad Sci U S A. 1997; 94(13): 6670–5. 9192623
28. Gardiol D, Kühne C, Glaunsinger B, Lee SS, Javier R, Banks L, Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene. 1999; 18(40): 5487–96. 10523825
29. Tonikian R, Zhang Y, Sazinsky SL, Currell B, Yeh JH, Reva B, Held HA, Appleton BA, Evangelista M, Wu Y, Xin X, Chan AC, Seshagiri S, Lasky LA, Sander C, Boone C, Bader GD, Sidhu SS, A specificity map for the PDZ domain family. PLoS Biol. 2008;6(9):e239. doi: 10.1371/journal.pbio.006023918828675
30. Nakagawa S, Huibregtse JM, Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol Cell Biol. 2000; 20(21): 8244–53. 11027293
31. Thomas M, Massimi P, Navarro C, Borg JP, Banks L, The hScrib/Dlg apico-basal control complex is differentially targeted by HPV-16 and HPV-18 E6 proteins. Oncogene. 2005; 24(41): 6222–30. 16103886
32. Hernández-Monge J, Garay E, Raya-Sandino A, Vargas-Sierra O, Díaz-Chávez J, Popoca-Cuaya M, et al. Papillomavirus E6 oncoprotein up-regulates occludin and ZO-2 expression in ovariectomized mice epidermis. Exp Cell Res. 2013; 319(17): 2588–603doi: 10.1016/j.yexcr.2013.07.02823948304
33. Halec G, Alemany L, Lloveras B, Schmitt M, Alejo M, Bosch FX, Tous S, Klaustermeier JE, Guimerà N, Grabe N, Lahrmann B, Gissmann L, Quint W, Bosch FX, de Sanjose S, Pawlita M, Retrospective International Survey and HPV Time Trends Study GroupRetrospective International Survey and HPV Time Trends Study GroupPathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer. J Pathol. 2014Dec;234(4):441–51. doi: 10.1002/path.440525043390
34. Massimi P, Zori P, Roberts S, Banks L, Differential regulation of cell-cell contact, invasion and anoikis by hScrib and hDlg in keratinocytes. PLoS One2012doi: 10.1371/journal.pone.0040279
35. Wu M, Pastor-Pareja JC, Xu T, Interaction between Ras(V12) and scribbled clones induces tumor growth and invasion. Nature. 2010; 463(7280): 545. doi: 10.1038/nature0870220072127
36. Young LC, Hartig N, Muñoz-Alegre M, Oses-Prieto JA, Durdu S, Bender S, Vijayakumar V, Vietri Rudan M, Gewinner C, Henderson S, Jathoul AP, Ghatrora R, Lythgoe MF, Burlingame AL, Rodriguez-Viciana P, An MRAS, SHOC2, and SCRIB complex coordinates ERK pathway activation with polarity and tumorigenic growth. Mol Cell. 2013Dec12;52(5):679–92. doi: 10.1016/j.molcel.2013.10.00424211266
37. Elsum IA, Yates LL, Pearson HB, Phesse TJ, Long F, O'Donoghue R, Ernst M, Cullinane C, Humbert PO, Scrib heterozygosity predisposes to lung cancer and cooperates with KRas hyperactivation to accelerate lung cancer progression in vivo. Oncogene. 2014; 33(48): 5523–5533. doi: 10.1038/onc.201324276238
38. Zhan L, Rosenberg A, Bergami KC, Yu M, Xuan Z, Jaffe AB, Allred C, Muthuswamy SK, Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma. Cell. 2008Nov28;135(5):865–78. doi: 10.1016/j.cell.2008.09.04519041750
39. Feigin ME, Akshinthala SD, Araki K, Rosenberg AZ, Muthuswamy LB, Martin B, Lehmann BD, Berman HK, Pietenpol JA, Cardiff RD, Muthuswamy SK, Mislocalization of the Cell Polarity Protein Scribble Promotes Mammary Tumorigenesis and Is Associated with Basal Breast Cancer. Cancer Res. 2014; 74(11): 3180–3194. doi: 10.1158/0008-5472.CAN-13-341524662921
40. Kranjec C, Tomaic V, Massimi P, Nicolaides L, Doorbar J, Banks L, The high-risk HPV E6 target scribble (hScrib) is required for HPV E6 expression in cervical tumour-derived cell lines. Papillomavirus Res. 2016.; 2: 70–77.
41. Boucamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE, Normal keratinization in a spontaneously immortalised aneuploid human keratinocyte cell line. J Cell.Biol. 1988; 106:761–771. 2450098
42. Wigler M, Sweet R, Sim GK, Wold B, Pellicer A, Lacy E, Maniatis T, Silverstein S, Axel R, Transformation of mammalian cells with genes from procaryotes and eucaryotes. Cell. 1979; 16(4): 777–85. 222468
43. Flores ER, Allen-Hoffmann BL, Lee D, Sattler CA, Lambert PF, Establishment of the human papillomavirus type 16 (HPV-16) life cycle in an immortalized human foreskin keratinocyte cell line. Virology. 1999; 262: 344–35410502513
44. Allen-Hoffmann BL, Schlosser SJ, Ivarie CAR, Sattler CA, Meisner LF, O'Connor SL, Normal growth and differentiation in a spontaneously immortalised near-diploid human keratinocyte cell line, NIKS. J Invest Dermatol. 2000; 114(3): 444–445. 10692102
45. Tomaić V, Gardiol D, Massimi P, Ozbun M, Myers M, Banks L, Human and primate tumour viruses use PDZ binding as an evolutionarily conserved mechanism of targeting cell polarity regulators. Oncogene. 2009; 28; 1–8. doi: 10.1038/onc.2008.36518820705